North America Topical Drug Delivery Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024

October 2017 | 150 pages | ID: N1E144EFA83EN
Data Bridge Market Research

Abstracts

In this region, The North America topical drug delivery market is projected to reach USD 89.3 million by 2024, from USD 48.0 million in 2016 growing at a CAGR of 8.0% in the forecast period 2017 to 2024.

Based on geography, the North America topical drug delivery market is segmented into 3 geographical regions, such as,

• U.S.
• Mexico
• Canada

North America topical drug delivery market competition by top players including

Galderma Pharma, S.A., dominated the topical drug delivery market accounting for a highest market share in 2016, followed by Bayer AG, and Valeant Pharmaceuticals. Some of the other players in the North America topical drug delivery market are

• MedPharm, Janssen Pharmaceuticals, Inc. (A J&J Company)
• Crescita Therapeutics
• West Pharmaceutical Services
• Biofarmitalia s.r.l
• Pharmatek Laboratories, Inc.
• Stiefel Laboratories, Inc.
• Tapemark, Acrux Limited
• Nitto Denko Corporation
• Skinvisible Pharmaceuticals, Inc.
• Mylan Pharmaceuticals Inc.
• Pocono Coated Products LLC
• TheraSolve NV.
• Samyang Biopharmaceuticals Corporation
• Lohmann Therapie-Systeme AG
• Prosollus Pharmaceuticals
• Easton Pharmaceuticals Inc.
• Novosis AG
• Endo Pharmaceuticals Inc.
• Transdermal Technologies, Inc.
• Sheffield Pharmaceuticals, Inc.
• Solvay

The North America topical drug delivery market is segmented on the basis of product type, indication, distribution channel, end user and geography.

On the basis of product type the market is segmented into transdermal drug delivery devices and topical drug delivery formulations.

Topical drug delivery formulations are further segmented based on form into solid, semi-solid and liquid. The semi solid segment is further classified into ointments, creams, lotions, gels and pastes. The solid drugs segment is further segmented into powders and suppositories.

The liquid drugs segment is further classified into solutions and suspensions. The transdermal drug delivery devices market segment is further segmented into patches and gels.

The topical drug delivery market is segmented on the basis of indications into 4 types such as acne, anesthetics, psoriasis, dermatitis & atopic dermatitis, rosacea, onychomycosis, alopecia, actinic keratosis, and others.

On the basis of end users the market is segmented into hospitals, home healthcare, clinics, diagnostic centers, and others.

Contents

1. INTRODUCTION

1.1. OVERVIEW OF NORTH AMERICA TOPICAL DRUG DELIVERY MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED

2. MARKET SEGMENTATION

2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS

3. MARKET OVERVIEW

3.1. DRIVERS
  3.1.1. RISING CASES OF ACUTE AND CHRONIC DISEASE
  3.1.2. RISING AGING POPULATION
  3.1.3. TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS
  3.1.4. APPROVAL OF NEW DRUGS
  3.1.5. BETTER OPPORTUNITY IN PHARMERGING MARKETS
3.2. RESTRAINTS
  3.2.1. REGULATORY SCENARIO AND PRICING PRESSURE
3.3. OPPORTUNITY
  3.3.1. ENERGING MARKET
  3.3.2. RISING ACCEPTANCE FOR SELF-ADMINISTRATION OF DRUGS
3.4. CHALLENGES
  3.4.1. PRODUCT RECALL
  3.4.2. PENETRATION INTO THE SMALLER MARKETS

4. PREMIUM INSIGHTS

5. EXECUTIVE SUMMARY

6. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY TYPE

6.1. OVERVIEW
6.2. TRANSDERMAL DRUG DELIVERY SYSTEMS (TDDS)
6.3. TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
6.4. LIQUID TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
6.5. SEMI SOLID TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
6.6. SOLID TOPICAL DRUG FORMULATION, BY PRODUCT TYPE

7. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY INDICATION

7.1. OVERVIEW
7.2. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY INDICATION
7.3. NORTH AMERICA ANTI-INFECTIVE TOPICAL DRUG DELIVERY MARKET, BY INDICATION

8. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL

8.1. OVERVIEW
8.2. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL

9. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY END USER

9.1. OVERVIEW

10. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY GEOGRAPHY

10.1. OVERVIEW
10.2. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET
  10.2.1. U.S. TOPICAL DRUG DELIVERY MARKET
  10.2.2. CANADA TOPICAL DRUG DELIVERY MARKET
  10.2.3. MEXICO TOPICAL DRUG DELIVERY MARKET

11. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, COMPANY SHARE

11.1. COMPANY SHARE ANALYSIS: NORTH AMERICA

12. COMPANY PROFILES

12.1. GALDERMA PHARMA S.A.
  12.1.1. COMPANY OVERVIEW
  12.1.2. FINANCIAL OVERVIEW
  12.1.3. PRODUCT PORTFOLIO
  12.1.4. RECENT DEVELOPMENTS
12.2. HISAMITSU PHARMACEUTICAL CO., INC.
  12.2.1. COMPANY OVERVIEW
  12.2.2. REVENUE ANALYSIS
  12.2.3. PRODUCT PORTFOLIO
  12.2.4. RECENT DEVELOPMENTS
12.3. PFIZER INC.
  12.3.1. COMPANY OVERVIEW
  12.3.2. REVENUE ANALYSIS
  12.3.3. PRODUCT PORTFOLIO
  12.3.4. RECENT DEVELOPMENTS
12.4. ABBVIE INC.
  12.4.1. COMPANY OVERVIEW
  12.4.2. REVENUE ANALYSIS
  12.4.3. PRODUCT PORTFOLIO
  12.4.4. RECENT DEVELOPMENTS
12.5. BAYER AG
  12.5.1. COMPANY OVERVIEW
  12.5.2. REVENUE ANALYSIS
  12.5.3. PRODUCT PORTFOLIO
  12.5.4. RECENT DEVELOPMENTS
12.6. 3M
  12.6.1. COMPANY OVERVIEW
  12.6.2. REVENUE ANALYSIS
  12.6.3. PRODUCT PORTFOLIO
  12.6.4. RECENT DEVELOPMENTS
12.7. ANTARES PHARMA, INC.
  12.7.1. COMPANY OVERVIEW
  12.7.2. REVENUE ANALYSIS
  12.7.3. PRODUCT PORTFOLIO
  12.7.4. RECENT DEVELOPMENTS
12.8. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
  12.8.1. COMPANY OVERVIEW
  12.8.2. REVENUE ANALYSIS
  12.8.3. PRODUCT PORTFOLIO
  12.8.4. RECENT DEVELOPMENTS
12.9. ALLERGAN PLC.
  12.9.1. COMPANY OVERVIEW
  12.9.2. REVENUE ANALYSIS
  12.9.3. PRODUCT PORTFOLIO
  12.9.4. RECENT DEVELOPMENTS
12.10. KAKEN PHARMACEUTICALS CO., LTD
  12.10.1. COMPANY OVERVIEW
  12.10.2. REVENUE ANALYSIS
  12.10.3. PRODUCT PORTFOLIO

13. RELATED REPORTS

List Of Tables

LIST OF TABLES

TABLE 1 NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY COUNTRY, 2015 – 2024 (USD BILLION)
TABLE 2 NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY TYPE, 2015 – 2024(USD BILLION)
TABLE 3 NORTH AMERICA TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 4 NORTH AMERICA TOPICAL FORMULATION MARKET, BY FORM, 2015– 2024 (USD BILLION)
TABLE 5 NORTH AMERICA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION)
TABLE 6 NORTH AMERICA LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION)
TABLE 7 NORTH AMERICA SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015– 2024 (USD BILLION)
TABLE 8 NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015 – 2024 (USD BILLION)
TABLE 9 NORTH AMERICA ANTI INFECTIVE TOPICAL DRUG DELIVERY MARKET, BY INDICATION, 2015– 2024 (USD BILLION)
TABLE 10 NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015– 2024 (USD BILLION)
TABLE 11 NORTH AMERICA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015– 2024 (USD BILLION)
TABLE 12 U.S. TRANSDERMAL DRUG MARKET, BY TYPE,2014 – 2024 (USD BILLION)
TABLE 13 U.S. TOPICAL FORMULATION MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 14 U.S. TOPICAL FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
TABLE 15 U.S.SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 16 U.S.LIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION)
TABLE 17 U.S.SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 18 U.S. TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 19 U.S. TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
TABLE 20 CANADA TRANSDERMAL DRUG MARKET, BY TYPE, 2014 – 2024 (USD BILLION)
TABLE 21 CANADA TOPICAL FORMULATION MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 22 CANADA TOPICAL FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
TABLE 23 CANADA SEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 24 CANADALIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION)
TABLE 25 CANADASOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 26 CANADA TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 27 CANADA TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)
TABLE 28 MEXICO TRANSDERMAL DRUG MARKET, BY TYPE,2014 – 2024 (USD BILLION)
TABLE 29 MEXICO TOPICAL FORMULATION MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION)
TABLE 30 MEXICO TOPICAL FORMULATION MARKET, BY FORM, 2015 – 2024 (USD BILLION)
TABLE 31 MEXICOSEMI-SOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 32 MEXICOLIQUID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE 2015 – 2024 (USD BILLION)
TABLE 33 MEXICOSOLID TOPICAL DRUG DELIVERY FORMULATIONS, BY TYPE, 2015 – 2024 (USD BILLION)
TABLE 34 MEXICO TOPICAL DRUG DELIVERY MARKET, BY END USER, 2015 – 2024 (USD BILLION)
TABLE 35 MEXICO TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 2015 – 2024 (USD BILLION)

List Of Figures

LIST OF FIGURES

FIGURE 1 NORTH AMERICA TOPICAL DRUG DELIVERYMARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA TOPICAL DRUG DELIVERY MARKET: GEOGRAHIC SCOPE
FIGURE 3 NORTH AMERICA TOPICAL DRUG DELIVERYMARKET: DATA TRIANGULATION
FIGURE 4 NORTH AMERICA TOPICAL DRUG DELIVERY MARKET: SNAPSHOT
FIGURE 5 NORTH AMERICA TOPICAL DRUG DELIVERYMARKET: BOTTOM UP APPROACH
FIGURE 6 NORTH AMERICA TOPICAL DRUG DELIVERYMARKET: TOP DOWN APPROACH
FIGURE 7 NORTH AMERICA TOPICAL DRUG DELIVERYMARKET: INTERVIEWS BY REGION AND DESIGNATION
FIGURE 8 NORTH AMERICA IS EXPECTED TO BE DOMINATE THE MARKET FOR TOPICAL DRUG DELIVERY IN 2016 AND APAC IS EXPECTED TO GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD TO 2024
FIGURE 9 NORTH AMERICA TOPICAL DRUG DELIVERY MARKET: BY TYPE, SNAPSHOT 2016
FIGURE 10 NORTH AMERICA TOPICAL DRUG DELIVERY MARKET: BY INDICATION, SNAPSHOT 2016
FIGURE 11 NORTH AMERICA TOPICAL DRUG DELIVERY MARKET: BY DISTRIBUTION CHANNEL, SNAPSHOT 2016
FIGURE 12 NORTH AMERICA TOPICAL DRUG DELIVERYMARKET: BY END-USER, SNAPSHOT 2016
FIGURE 13 NORTH AMERICA TOPICAL DRUG DELIVERY MARKET:BY GEOGRAPHY, 2016
FIGURE 14 NORTH AMERICA TOPICAL DRUG DELIVERY PRESCRIPTION DRUGS MARKET: COMPANY SHARE 2016 (%)